title: Automated high throughput screening for serine kinase inhibitors using a LEADseeker scintillation proximity assay in the 1536-well format.
abstract: High-throughput screening in the 1536-well format has been largely restricted to solution-based and cell-based screens. In this article, we show the feasibility of a completely automated, robust scintillation proximity assay in the 1536-well format that is suitable to identify inhibitors for a serine/threonine kinase from a compound library. The introduction of [(33)P]phosphate into a biotinylated peptide substrate mirrors the activity of the kinase. The peptide is immobilized on streptavidin-coated LEADseeker imaging beads and [(33)P]phosphate incorporation is detected with the LEADseeker imaging system of Amersham Pharmacia Biotech. To improve the liquid handling procedures for imaging bead suspensions in the low microliter range, we developed a novel trough with an integrated stirring function. A comparison of the 1536-well assay to a 384-well assay revealed a comparable assay quality with Z' factors of about 0.7 for the 384-well format and 0.6 for the 1536-well format. In an automated screen of a random compound collection, 94.4% of the inhibitory compounds could be identified with both assay formats. Dose-response curves were performed for a selection of identified kinase inhibitors and revealed similar IC(50) values for both assay formats.
authors.affiliation: Department of Integrated Lead Discovery, Boehringer Ingelheim Pharma KG, Biberach, Germany. gabriele.sorg@bc.boehringer-ingelheim.com
authors.forename: Gabriele
authors.initials: G
authors.lastname: Sorg
authors.forename: Hans-Dieter
authors.initials: HD
authors.lastname: Schubert
authors.forename: Frank H
authors.initials: FH
authors.lastname: Büttner
authors.forename: Ralf
authors.initials: R
authors.lastname: Heilker
mesh_terms: D001331:Automation; D001710:Biotin / Q000737:chemistry; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D004791:Enzyme Inhibitors / Q000737:chemistry*; D006801:Humans; D020128:Inhibitory Concentration 50; D010455:Peptides / Q000737:chemistry; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D013997:Time Factors
chemical_list: D004791:Enzyme Inhibitors; D010455:Peptides; D001710:Biotin; D017346:Protein Serine-Threonine Kinases